Novo NordiskNVO announced positive data from a 26 week, parallel group, randomized, open label, head to head study (LIRA LIXI) comparing the efficacy and safety of Victoza to Sanofi’s SNY Lyxumia, both as add on to metformin, for the
Novo Nordisk's Victoza Fares Better than Sanofi's Lyxumia
